Skip to content

Pre-calculation for Frequency Lowering With Hearing Devices

Pre-calculation for Frequency Lowering With Hearing Devices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05733169
Enrollment
8
Registered
2023-02-17
Start date
2023-01-16
Completion date
2023-04-04
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frequency Lowering

Brief summary

Perceptual evaluation of the parametrization and pre-calculation of frequency lowering requires the participation of subjects with hearing loss.

Interventions

OTHERFrequency lowering intervention

Modified parametrization of the current frequency lowering parametrization.

OTHERFrequency lowering reference

Current frequency lowering parametrization

Sponsors

Sonova AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Experienced hearing aid user (minimum use duration 1 year) * Adult (minimum age: 18 years), * Experience with frequency lowering, * Hearing thresholds with N5-N7, S1, S2, S3 hearing loss * Symmetrical hearing loss (difference between ears \<= 10 dB for 1kHz-6kHz) , * Sensorineural hearing loss, * Air Conduction - bone conduction gap \<= 10 dB, * Written and spoken German, * Ability to understand instruction, * Ability to describe listening experiences, * Ability to attend to the appointments, * Ability to fill in a questionnaire conscientiously * Healthy outer ear (without previous surgical procedures) * Hearing loss within the fitting ranges of the investigational product, * Informed consent as documented by signature.

Exclusion criteria

* Clinical contraindications deformity of the ear (closed ear canal * or absence of pinna), * Not willing to wear the hearing aid, * Fluctuating hearing that could influence the results, * Contraindications to the MD in this study, e.g. known hypersen-sitivity or allergy to the investigational product, * Limited mobility and not in the position to attend all appoint-ments, * Limited ability to describe listening impressions/experiences and the use of the hearing aid, * Inability to produce a reliable hearing test result, * Massively limited dexterity, * Known psychological problems, * Known central hearing disorders.

Design outcomes

Primary

MeasureTime frame
Measurement of sound quality and audibility of high-frequency sounds for hearing-impaired subjects with the new parametrization compared to the current implementation of the parametrization.6 weeks

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026